Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.70

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.29

Views

Views
June 20253
July 202517
August 20250
September 20252
October 20252
November 20252
December 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil12
United States7
Kenya2
Argentina2
Germany1
Egypt1
Spain1
United Kingdom1
Paraguay1
South Africa1
 

Top cities views

Views
Arlington Heights1
Asunción1
Cairo1
Cape Town1
Cedar Rapids1
Chattanooga1
Coventry1
Duque de Caxias1
Ituiutaba1
Lomas de Zamora1